Stockscreener 앱 받기
3.76%
전일 마감가:
$283.95
열려 있는:
$282.44
하루 거래량:
881.81K
Relative Volume:
0.63
시가총액:
$32.87B
수익:
$126.36B
순이익/손실:
$1.30B
주가수익비율:
25.61
EPS:
10.6697
순현금흐름:
$1.55B
1주 성능:
-1.29%
1개월 성능:
+5.86%
6개월 성능:
+20.62%
1년 성능:
-0.91%
1일 변동 폭
$271.57
$283.08
1주일 범위
$269.21
$285.61
52주 변동 폭
$206.87
$315.35
휴매너 Stock (HUM) Company Profile
명칭
Humana Inc
전화
(502) 580-1000
주소
500 W MAIN ST, LOUISVILLE, KY
HUM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HUM
Humana Inc
|
273.28 | 34.15B | 126.36B | 1.30B | 1.55B | 10.67 |
|
UNH
Unitedhealth Group Inc
|
331.02 | 307.04B | 435.16B | 18.37B | 17.37B | 19.16 |
|
CVS
Cvs Health Corp
|
78.60 | 103.28B | 393.94B | 428.00M | 6.29B | 0.3826 |
|
ELV
Elevance Health Inc
|
374.87 | 84.88B | 194.82B | 5.53B | 3.77B | 24.45 |
|
CI
Cigna Group
|
272.21 | 74.24B | 268.22B | 6.55B | 7.44B | 22.67 |
휴매너 Stock (HUM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-07 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-12-05 | 업그레이드 | Jefferies | Hold → Buy |
| 2025-10-14 | 개시 | Goldman | Sell |
| 2025-09-22 | 개시 | Evercore ISI | In-line |
| 2025-05-01 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2024-11-06 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2024-10-11 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2024-10-08 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2024-10-07 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-10-07 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2024-10-03 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-10-02 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2024-10-02 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-10-02 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2024-06-26 | 개시 | Piper Sandler | Overweight |
| 2024-06-24 | 개시 | Morgan Stanley | Equal-Weight |
| 2024-04-02 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-03-22 | 개시 | Raymond James | Mkt Perform |
| 2024-03-13 | 다운그레이드 | Argus | Buy → Hold |
| 2024-03-06 | 개시 | Barclays | Equal Weight |
| 2024-01-26 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2024-01-25 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2023-12-12 | 업그레이드 | Argus | Hold → Buy |
| 2023-11-08 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-07-07 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2023-06-23 | 다운그레이드 | Argus | Buy → Hold |
| 2023-04-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-12-13 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-10-26 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2022-09-20 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-06-17 | 개시 | Loop Capital | Buy |
| 2022-05-27 | 개시 | Bernstein | Mkt Perform |
| 2022-04-13 | 업그레이드 | UBS | Neutral → Buy |
| 2022-01-06 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2021-12-16 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-14 | 개시 | Goldman | Neutral |
| 2021-11-04 | 재확인 | Barclays | Overweight |
| 2021-11-04 | 재확인 | Credit Suisse | Outperform |
| 2021-11-04 | 재확인 | Morgan Stanley | Overweight |
| 2021-11-04 | 재확인 | Oppenheimer | Outperform |
| 2021-11-04 | 재확인 | RBC Capital Mkts | Outperform |
| 2021-09-27 | 개시 | SVB Leerink | Outperform |
| 2021-09-10 | 개시 | Cowen | Outperform |
| 2021-09-09 | 재개 | Barclays | Overweight |
| 2021-07-09 | 개시 | Seaport Global Securities | Neutral |
| 2021-05-19 | 개시 | Wells Fargo | Equal Weight |
| 2021-01-04 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-10-02 | 개시 | Bernstein | Mkt Perform |
| 2020-07-01 | 개시 | SVB Leerink | Outperform |
| 2020-06-16 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2020-06-05 | 개시 | Goldman | Buy |
| 2020-01-03 | 재확인 | JP Morgan | Overweight |
| 2019-10-18 | 개시 | Mizuho | Buy |
| 2019-09-30 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-12 | 개시 | Deutsche Bank | Hold |
| 2019-08-12 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2019-04-23 | 개시 | UBS | Neutral |
| 2019-01-14 | 개시 | Stephens | Overweight |
| 2018-12-20 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-11-08 | 재확인 | BofA/Merrill | Buy |
| 2018-09-13 | 개시 | Barclays | Overweight |
| 2018-07-12 | 재개 | Morgan Stanley | Overweight |
| 2018-07-06 | 재확인 | Piper Jaffray | Overweight |
| 2018-06-01 | 재개 | Citigroup | Buy |
| 2018-02-08 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2018-02-08 | 재확인 | Leerink Partners | Outperform |
| 2018-01-12 | 업그레이드 | Jefferies | Hold → Buy |
모두보기
휴매너 주식(HUM)의 최신 뉴스
Expanded Oncology Partnership With Atlas Could Be A Game Changer For Humana (HUM) - Yahoo Finance
Graves Gilbert Clinic, Humana reach 2-year agreement for uninterrupted patient care - WBKO
Leading Through Change: How Humana is Preparing for 2026 and Beyond - Humana
Humana Medicaid Plans in South Carolina and Wisconsin Receive 2025 Press Ganey Human Experience Pinnacle of Excellence Award - Humana
Bruce Broussard On Leaving Humana, Reputational Risks of AI - Newsweek
The Truth About Humana Inc.: Why Everyone Is Suddenly Watching This Stock - AD HOC NEWS
Humana (HUM) Valuation Check As New Cancer Care Alliance Targets Medicare Advantage Growth - simplywall.st
Graves Gilbert Clinic reaches 2-year agreement with Humana - WCLU Radio
Graves Gilbert Clinic, Humana reach two-year agreement - WNKY
Graves Gilbert announces renewed partnership with Humana - WBKO
Humana Inc. $HUM Stake Decreased by Manning & Napier Advisors LLC - MarketBeat
Humana Inc. (NYSE:HUM) Receives Average Rating of "Hold" from Brokerages - MarketBeat
Humana And Mark Cuban Exploring Potential Pharmacy Partnership - marketscreener.com
Humana Partners With Atlas to Enhance Cancer Care for Seniors - Zacks Investment Research
Humana sells two Medical Center office buildings valued at $11.3M - San Antonio Express-News
Pacific Capital Partners Ltd Takes Position in Humana Inc. $HUM - MarketBeat
Humana partners with Atlas Oncology to enhance cancer care services By Investing.com - Investing.com Australia
Humana partners with Atlas Oncology for Medicare cancer care in two states - StreetInsider
Humana Expands Cancer Care for Medicare Advantage Members Through Atlas Oncology Partnership - The Joplin Globe
Humana’s Nomination Committee Backs Full Board Re-Election and Continued Chairmanship - TipRanks
Humana’s Jim Rechtin won’t back down on Medicare Advantage - Modern Healthcare
Spire Wealth Management Boosts Position in Humana Inc. $HUM - MarketBeat
SG Americas Securities LLC Boosts Holdings in Humana Inc. $HUM - MarketBeat
Humana (HUM) Valuation Check After Mixed Shareholder Returns And New Discount To Analyst Targets - Yahoo Finance
In Snohomish County, new year brings changes to health insurance - Everett Herald
How Recent Margin Concerns Are Shaping Humana’s (HUM) Evolving Valuation Story - Yahoo Finance
User | times-online.comHumana Inc. to Release Fourth Quarter 2025 Results on February 11, 2026 - FinancialContent
Will Humana Inc. stock recover faster than peers2025 Bull vs Bear & Free Community Consensus Stock Picks - ulpravda.ru
What is the fair value of Humana Inc. stock nowWeekly Investment Report & Stock Market Timing Techniques - ulpravda.ru
February 27th Options Now Available For Humana (HUM) - Nasdaq
Robeco Institutional Asset Management B.V. Acquires 41,962 Shares of Humana Inc. $HUM - MarketBeat
HUM SEC FilingsHumana 10-K, 10-Q, 8-K Forms - Stock Titan
Humana (HUM) Valuation Check After Recent Share Price Recovery And Mixed Long Term Returns - simplywall.st
Humana Inc. stock outperforms competitors despite losses on the day - MarketWatch
Humana (HUM): Wells Fargo Downgrades Rating to Equal-Weight | HU - GuruFocus
Wells sees tougher backdrop for healthcare stocks, cuts Humana, UnitedHealth - Investing.com Canada
Humana (HUM) Downgraded by Wells Fargo Amid Margin Concerns - GuruFocus
Wells Fargo downgrades Humana to Equal Weight on margin concerns - TipRanks
Analyst recommendations: Amcor, Bank of America, Block, Crocs, Humana… - MarketScreener
HUMANA MARKET POINTAd from 2026-01-07 - Kenosha News
Humana Inc.: Can a Health Insurance Platform Behave Like a Tech Product? - AD HOC NEWS
Humana Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Is Humana (HUM) Offering Value After DCF And P/E Suggest Upside Potential - Yahoo Finance
CWA Asset Management Group LLC Raises Holdings in Humana Inc. $HUM - MarketBeat
Humana Inc. stock outperforms competitors on strong trading day - MarketWatch
Humana (HUM) director David T. Feinberg adds shares and deferred RSUs - Stock Titan
Humana Inc. (HUM) director details share disposition and deferred RSUs - Stock Titan
Humana Inc. (HUM) director discloses deferred restricted stock unit awards - Stock Titan
Humana (NYSE: HUM) director logs stock sale, 766 RSUs and dividend units - Stock Titan
Humana (NYSE: HUM) director discloses RSU grants and GRAT share holdings - Stock Titan
Humana Inc. (HUM) director Mesquita granted 766 restricted stock units - Stock Titan
휴매너 (HUM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.22%
0.00%
자본화:
|
볼륨(24시간):